Anton Dobrin

9PUBLICATIONS
56CO-AUTHORS
Haematological tumoursMolecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Carbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 30, 2026
Solving the puzzle of CD8 T cell positive selection.

Juan Carlos Zúñiga-Pflücker, Anton Dobrin

|Feb 26, 2026
Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction.

Nayan Jain, Yuzhe Shi, Celina May

|Jan 30, 2025
HIV immune evasin Nef enhances allogeneic CAR T cell potency.

Karlo Perica, Ivan S Kotchetkov, Jorge Mansilla-Soto

|Mar 20, 2024
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies.

Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi

|Nov 07, 2023
Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function.

Nayan Jain, Zeguo Zhao, Richard P Koche

|May 10, 2023
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.

Luis A Rojas, Zachary Sethna, Kevin C Soares

Pageof 2